Associative Memory Impairments arising from Neurodegenerative Diseases and Traumatic Brain Injuries in a Hopfield Network Model
Neurodegenerative diseases and traumatic brain injuries (TBI) are among the main causes of cognitive dysfunction in humans. Both manifestations exhibit the extensive presence of focal axonal swellings (FAS). FAS compromises the information encoded in spike trains, thus leading to potentially severe functional deficits. Complicating our understanding of the impact of FAS is our inability to access small scale injuries with non-invasive methods, the overall complexity of neuronal pathologies, and our limited knowledge of how networks process biological signals. Building on Hopfield's pioneering work, we extend a model for associative memory to account for FAS and its impact on memory encoding. We calibrate all FAS parameters from biophysical observations of their statistical distribution and size, providing a framework to simulate the effects of brain disorders on memory recall performance. A face recognition example is used to demonstrate and validate the functionality of the novel model. Our results link memory recall ability to observed FAS statistics, allowing for a description of different stages of brain disorders within neuronal networks. This provides a first theoretical model to bridge experimental observations of FAS in neurodegeneration and TBI with compromised memory recall, thus closing the large gap between theory and experiment on how biological signals are processed in damaged, high-dimensional functional networks. The work further lends new insight into positing diagnostic tools to measure cognitive deficits.
Code (1)
Tasks
DiagnosticFace RecognitionSimilar Papers 제목 키워드 기반
p75NTR as a Molecular Memory Switch
In recent years, many molecular and environmental factors have been studied to understand how synaptic plasticity is modulated. Sleep, as an evolutionary conserved biological function, has shown to be a critical player f…
Vocal markers from sustained phonation in Huntington's Disease
Disease-modifying treatments are currently assessed in neurodegenerative diseases. Huntington's Disease represents a unique opportunity to design automatic sub-clinical markers, even in premanifest gene carriers. We inve…
regressionKnowledge Graph-based Neurodegenerative Diseases and Diet Relationship Discovery
To date, there are no effective treatments for most neurodegenerative diseases. However, certain foods may be associated with these diseases and bring an opportunity to prevent or delay neurodegenerative progression. Our…
Literature MiningModeling cognitive deficits following neurodegenerative diseases and traumatic brain injuries with deep convolutional neural networks
The accurate diagnosis and assessment of neurodegenerative disease and traumatic brain injuries (TBI) remain open challenges. Both cause cognitive and functional deficits due to focal axonal swellings (FAS), but it is di…
PrognosisMeta-analysis of Gene Expression in Neurodegenerative Diseases Reveals Patterns in GABA Synthesis and Heat Stress Pathways
Neurodegenerative diseases are characterized as the progressive loss of neural cells, e.g. neurons, glial cells. Ageing, monogenic variations, viral infections, and many other factors are determined and speculated as cau…